Some of the shaily’s prominent clientele as per AR’24 are
It seems like Adalvo is the first generic to secure EU approval for Liraglutide pre-filled pen.
https://www.globenewswire.com/news-release/2024/06/13/2898123/0/en/Adalvo-Secures-First-EU-Generic-Approval-for-Liraglutide-Pre-Filled-Pen.html
Also, pharmathen seems to be working with Sandoz on Semaglutide. And Sandoz plans to launch a semaglutide generic drug in Canada when the patent for the main ingredient of diabetic and weight-loss drugs like Ozempic and Wegovy wears off in 2026.
https://www.bnnbloomberg.ca/business/company-news/2024/09/03/sandoz-plans-first-glp1-generic-drug-launch-in-canada-in-2026/
Alvogen seems to be a major player in Teriperatide.
Glenmark has launched a bio-similar for Liraglutide in India in January under brand name Lirafit.
Details of patent expiry of some of the GLP-1 drugs in India
just trying to understand take off potential of shaily’s injector pens
| Subscribe To Our Free Newsletter |
